Milestone Pharmaceuticals (MIST) Retained Earnings (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Retained Earnings of -$456.7 million for Q1 2026, down 812.39% on a QoQ basis from $64.1 million in Q4 2025, and down 17.61% year-over-year from -$554.3 million in Q1 2025.
Milestone Pharmaceuticals (MIST) Retained Earnings (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Retained Earnings history runs 9 years deep, the most recent figure standing at -$456.7 million for Q1 2026.
- Quarterly Retained Earnings fell 17.61% year-over-year to -$456.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$456.7 million (down 17.61% YoY) and the FY2025 annual result came in at $64.1 million, up 117.44% from the prior year.
- Retained Earnings was -$456.7 million for Q1 2026 at Milestone Pharmaceuticals, down from $64.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $64.1 million in Q4 2025 and bottomed at -$456.7 million in Q1 2026.
- A 5-year average of -$152.0 million and a median of $17.8 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 2109.33% — and 2025, when it jumped 117.44%.
- Milestone Pharmaceuticals' Retained Earnings stood at $24.4 million in 2022, then soared by 38.45% to $33.8 million in 2023, then slumped by 1186.32% to -$367.5 million in 2024, then jumped by 117.44% to $64.1 million in 2025, then slumped by 812.39% to -$456.7 million in 2026.
- Business Quant data shows MIST's Retained Earnings at -$456.7 million in Q1 2026, $64.1 million in Q4 2025, and -$413.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | -456.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -456.67 Mn |
| Dec 31, 2025 | 64.10 Mn |
| Sep 30, 2025 | -413.20 Mn |
| Jun 30, 2025 | -401.27 Mn |
| Mar 31, 2025 | -388.30 Mn |
| Dec 31, 2024 | -367.55 Mn |
| Sep 30, 2024 | 38.11 Mn |
| Jun 30, 2024 | 36.71 Mn |
| Mar 31, 2024 | -336.40 Mn |
| Dec 31, 2023 | 33.83 Mn |
| Sep 30, 2023 | 31.96 Mn |
| Jun 30, 2023 | 29.11 Mn |
| Mar 31, 2023 | -281.30 Mn |
| Dec 31, 2022 | 24.44 Mn |
| Sep 30, 2022 | 22.44 Mn |
| Jun 30, 2022 | -237.00 Mn |
| Mar 31, 2022 | 17.79 Mn |
| Dec 31, 2021 | 15.71 Mn |
| Sep 30, 2021 | 13.79 Mn |
| Jun 30, 2021 | 11.80 Mn |